4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-23-018564
General Counsel and Secretary gave up 2,305 shares (to pay taxes)
- General Counsel and Secretary acquired 5,083 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2023-03-10 | Option exercise | +2,833 | 54,899 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2023-03-13 | Shares withheld for taxes | −1,283 | $43.22 | $55,451 | 53,616 | D |
| KASINGER JAMES R. General Counsel and Secretary | 2023-03-11 | Option exercise | +2,250 | 55,866 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2023-03-13 | Shares withheld for taxes | −1,022 | $43.22 | $44,171 | 54,844 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2023-03-10 | Option exercise · Restricted Stock Units | −2,833 | 0 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2023-03-10 | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2023-03-10 | Grant or award · Restricted Stock Units | +22,000 | 22,000 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2023-03-11 | Option exercise · Restricted Stock Units | −2,250 | 4,500 | D | ||
Loading xslF345X03/doc4.xml…